Target (CBDY) Enterprise Value (2013 - 2026)
Target (CBDY) reported Enterprise Value of -$209897.0 for Q1 2026, up 73.15% year-over-year from -$121223.5 in Q1 2025, and down 109.04% quarter-over-quarter from -$100410.0 in Q4 2025.
Target (CBDY) Enterprise Value (2013 - 2026) Analysis & Trends
Target (CBDY) has 14 years of Enterprise Value data on file, last reported at -$209897.0 in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$209897.0, up 73.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$209897.0 (up 73.15% YoY), and the FY2025 annual result was -$100410.0, up 94.65% from the prior year.
- Enterprise Value fell to -$209897.0 in Q1 2026 per CBDY's latest filing, from -$100410.0 in the prior quarter.
- Over five years, Enterprise Value peaked at -$57833.0 in Q1 2023 and troughed at -$1.9 million in Q4 2024.
- A 5-year average of -$712939.4 and a median of -$745019.0 in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2025: Enterprise Value slumped 1203.87% in 2024, then jumped 94.65% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$232333.0 in 2022, then tumbled by 220.67% to -$745019.0 in 2023, then plunged by 152.04% to -$1.9 million in 2024, then jumped by 94.65% to -$100410.0 in 2025, then slumped by 109.04% to -$209897.0 in 2026.
- Business Quant data shows CBDY's Enterprise Value at -$209897.0 in Q1 2026, -$100410.0 in Q4 2025, and -$337488.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -3.74 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -1.94 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -2.15 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -77.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -1.32 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -428.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -511.86 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -498.58 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -750.88 Mn |
| 10 | Target | - | - | 191,787.00 | -209,897.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -209,897.00 |
| Dec 31, 2025 | -100,410.00 |
| Sep 30, 2025 | -337,488.00 |
| Jun 30, 2025 | -845,927.00 |
| Mar 31, 2025 | -781,703.00 |
| Dec 31, 2024 | -1.88 Mn |
| Sep 30, 2024 | -1.29 Mn |
| Jun 30, 2024 | -1.74 Mn |
| Mar 31, 2024 | -754,070.00 |
| Dec 31, 2023 | -745,019.00 |
| Sep 30, 2023 | -453,922.00 |
| Jun 30, 2023 | -1.06 Mn |
| Mar 31, 2023 | -57,833.00 |
| Dec 31, 2022 | -232,333.00 |
| Sep 30, 2022 | -206,095.00 |
| Jun 30, 2021 | -96,641.00 |
| Mar 31, 2021 | -404,401.00 |
| Dec 31, 2020 | -181,629.00 |
| Sep 30, 2020 | -739,552.00 |
| Jun 30, 2020 | -2,946.00 |